Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Sep 13;16(5):467-477.
doi: 10.1007/s13770-019-00217-8. eCollection 2019 Oct.

Biomaterials for the Treatment of Tendon Injury

Affiliations
Review

Biomaterials for the Treatment of Tendon Injury

Sung Eun Kim et al. Tissue Eng Regen Med. .

Abstract

Background: Most tendon injuries are occurring from a gradual wearing and tearing of the tendon tissues from overuse. Such injuries are usually seen in sports, exercising, or daily activities that involve a high mechanical load and weight bearing. However, owing to the lack of both cellularity and blood vessels in tendons, the process of tendon repair is slow and inefficient. Although various conservative (non-surgical) and surgical management options are conducted by the clinicians, a gold standard of these approaches does not exist. In this regard, the treatment of tendon injuries is challenging.

Method: Here, we describe the recent advances of biomaterial-based approaches for the treatment of injured tendons.

Results: Regenerative medicine is an emerging multidisciplinary research that specializes in the repair of damaged tendon tissues through the delivery of regenerative factors by biomaterials.

Conclusion: Although current biomaterial-based treatment strategies have shown their potential for tendon healing, future research and clinical applications should focused on finding the optimum combinations of regenerative factors with ideal biomaterials for the repair of tendons.

Keywords: Biomaterials; Blood vessel; Delivery; Regenerative factor; Tendon healing.

PubMed Disclaimer

Conflict of interest statement

Conflict of interestThe authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Biological treatment approaches for tendon repair using injectable therapeutics containing platelet-rich plasma, cells, proteins, or genes
Fig. 2
Fig. 2
Magnetic resonance imaging T2-weighted images at 4 weeks after treatment. Transverse images of the treated tendon in the A saline, B Lr-PRP, C Lp-PRP, and D normal groups. Adapted from [25]. Red arrow means increased signal that indicates inflammatory edema
Fig. 3
Fig. 3
Representative bioluminescence image. Hydrogel + PRP + ASCs increased cell proliferation and survival in comparison to Hydrogel + ASCs. POD means post-operative day. Adapted from [72]. Scale bar means the biomuminescence signal intensity; red: high and blue: low
Fig. 4
Fig. 4
Local intratendinous injection of drug-loaded porous microspheres into a rat model of collagenase-induced tendinopathy. Collagenase injection into the tendon tissue increased the mRNA levels of the pro-inflammatory cytokines [matrix metalloproteinase (MMP)-3, MMP-13, cyclooxygenase-2 (COX-2), a disintegrin and metalloproteinase with thrombospondin motifs-5 (ADAMTS-5), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α)]. The increased pro-inflammatory cytokines induced collagen fiber disruption, resulting in decreased tensile strength. The local intratendinous injection of drug-loaded porous microspheres significantly reduced these pro-inflammatory cytokines, repairing the collagen fiber organization and tensile strength and leading to restoration of the tendon tissues
Fig. 5
Fig. 5
Color Doppler ultrasound of low (50 μg), mid (250 μg) and high (500 μg) dose anti-VEGF antibogy (B20) at days 7 and 14. Adapted from [86]. Color Doppler means the flow of blood based on its direction of flow; red towards to top of the transducer, blue away from the transducer. Red–orange and blue–sky blue indicate the different velocities of blood flow

References

    1. Aslan H, Kimelman-Bleich N, Pelled G, Gazit D. Molecular targets for tendon neoformation. J Clin Invest. 2008;118:439–444. - PMC - PubMed
    1. Wang JH. Mechanobiology of tendon. J Biomech. 2006;39:1563–1582. - PubMed
    1. Sharma P, Maffulli N. Biology of tendon injury: healing, modeling and remodeling. J Musculoskelet Neuronal Interact. 2006;6:181–190. - PubMed
    1. Khan KM, Maffulli N. Tendinopathy: an Achilles’ heel for athletes and clinicians. Clin J Sport Med. 1998;8:151–154. - PubMed
    1. Zhang J, Wang JH. Characterization of differential properties of rabbit tendon stem cells and tenocytes. BMC Musculoskelet Disord. 2010;11:10. - PMC - PubMed

Publication types

Substances

LinkOut - more resources